The Recall Desk
LowFDA (Devices)·Z-0516-2019·Announced 2018-12-05

Fresenius Granuflo Dry Acid Concentrate Recalled for Foreign Substance

Fresenius Medical Care is recalling Granuflo Dry Acid Concentrate for hemodialysis due to confirmed foreign substance contamination.

What this means for you

Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.

Our severity reasoning: The agency classified this as a Class III recall, which by definition is unlikely to cause adverse health consequences.

Plain-English summary

Fresenius Medical Care Renal Therapies Group, LLC is recalling 4,752 units of Fresenius Granuflo Dry Acid Concentrate- 2K 2.0 Ca 1 Mg 16.5 GAL (Catalog Number: OFD2201-3B). This product is used for hemodialysis.

The recall was initiated because discolored powder was found in the product, which confirmed the presence of a foreign substance. The affected lot code is 18ETGF005.

The product was distributed in the United States nationwide and in Mexico. Consumers and healthcare providers should stop using the affected product and contact the manufacturer for instructions on return or replacement.

The recalled product

Product
Fresenius Granuflo Dry Acid Concentrate- 2K 2.0 Ca 1 Mg 16.5 GAL Catalog Number: OFD2201-3B for hemodialysis
Affected units
4,752

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • Lot code:18ETGF005

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 3 recalled by Fresenius Medical Care Renal Therapies Group, LLC under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 3 products in this recall →